Severe achondroplasia with developmental delay and acanthosis nigricans
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is a rare genetic disorder characterized by achondroplasia, significant developmental delay, and acanthosis nigricans. This condition is caused by mutations in the FGFR3 gene, which plays a crucial role in bone growth and development.
Clinical Features[edit | edit source]
Individuals with SADDAN typically present with:
- Severe short stature due to achondroplasia
- Delayed developmental milestones
- Acanthosis nigricans, a skin condition characterized by dark, thick, velvety patches in body folds and creases
- Macrocephaly (abnormally large head)
- Hydrocephalus (accumulation of cerebrospinal fluid within the brain)
- Hypotonia (reduced muscle tone)
Genetics[edit | edit source]
SADDAN is caused by specific mutations in the FGFR3 gene, which encodes the fibroblast growth factor receptor 3. This gene is crucial for the regulation of bone growth and development. The mutations lead to an overactive FGFR3 protein, which disrupts normal bone growth and leads to the characteristic features of the disorder.
Diagnosis[edit | edit source]
Diagnosis of SADDAN is based on clinical evaluation, family history, and genetic testing to identify mutations in the FGFR3 gene. Prenatal diagnosis is possible if the mutation is known in the family.
Management[edit | edit source]
There is no cure for SADDAN, and treatment is primarily supportive and symptomatic. Management strategies may include:
- Physical therapy to improve motor skills and muscle strength
- Special education services to address developmental delays
- Regular monitoring and treatment of complications such as hydrocephalus and spinal stenosis
- Dermatological treatments for acanthosis nigricans
Prognosis[edit | edit source]
The prognosis for individuals with SADDAN varies depending on the severity of the symptoms and the presence of complications. Early intervention and supportive care can improve the quality of life for affected individuals.
Related Pages[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD